Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1988 1
1992 1
1993 1
1994 1
1995 3
1996 2
1997 2
1998 1
1999 2
2000 4
2001 4
2002 14
2003 18
2004 20
2005 26
2006 37
2007 38
2008 34
2009 40
2010 39
2011 42
2012 56
2013 68
2014 48
2015 55
2016 53
2017 42
2018 46
2019 40
2020 40
2021 37
2022 22
2023 9
2024 5
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

753 results

Results by year

Filters applied: . Clear all
Page 1
Esophageal cancer.
Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Ilson DH, Kleinberg LR, McAleer MF, Meropol NJ, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Swisher SG, Washington MK, Willett C, Wood DE, Wright CD, Yang G; NCCN Esophageal Cancer Panel. Ajani JA, et al. Among authors: fuchs cs. J Natl Compr Canc Netw. 2008 Oct;6(9):818-49. J Natl Compr Canc Netw. 2008. PMID: 18926093 No abstract available.
Response.
Ng K, Chan AT, Fuchs CS. Ng K, et al. Among authors: fuchs cs. J Natl Cancer Inst. 2015 Jun 4;107(8):djv150. doi: 10.1093/jnci/djv150. Print 2015 Aug. J Natl Cancer Inst. 2015. PMID: 26048995 Free PMC article. No abstract available.
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.
Fuchs CS, Tomasek J, Yong CJ, Dumitru F, Passalacqua R, Goswami C, Safran H, Dos Santos LV, Aprile G, Ferry DR, Melichar B, Tehfe M, Topuzov E, Zalcberg JR, Chau I, Campbell W, Sivanandan C, Pikiel J, Koshiji M, Hsu Y, Liepa AM, Gao L, Schwartz JD, Tabernero J; REGARD Trial Investigators. Fuchs CS, et al. Lancet. 2014 Jan 4;383(9911):31-39. doi: 10.1016/S0140-6736(13)61719-5. Epub 2013 Oct 3. Lancet. 2014. PMID: 24094768 Clinical Trial.
Colon cancer.
Benson AB 3rd, Arnoletti JP, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Engstrom PF, Enzinger PC, Fleshman JW Jr, Fuchs CS, Grem JL, Knol JA, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W Jr, Sofocleous CT, Venook AP, Willett C; National Comprehensive Cancer Network. Benson AB 3rd, et al. Among authors: fuchs cs. J Natl Compr Canc Netw. 2011 Nov;9(11):1238-90. doi: 10.6004/jnccn.2011.0104. J Natl Compr Canc Netw. 2011. PMID: 22056656 No abstract available.
Gastric cancer.
Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Das P, Denlinger C, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Meredith K, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Washington MK, Willett C, Wood DE, Wright CD, Yang G; NCCN Gastric Cancer Panel. Ajani JA, et al. Among authors: fuchs cs. J Natl Compr Canc Netw. 2010 Apr;8(4):378-409. doi: 10.6004/jnccn.2010.0030. J Natl Compr Canc Netw. 2010. PMID: 20410333 No abstract available.
Gemcitabine-induced radiation recall.
Jeter MD, Jänne PA, Brooks S, Burstein HJ, Wen P, Fuchs CS, Loeffler JS, Devlin PM, Salgia R. Jeter MD, et al. Among authors: fuchs cs. Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):394-400. doi: 10.1016/s0360-3016(02)02773-6. Int J Radiat Oncol Biol Phys. 2002. PMID: 12023144 Review.
Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study.
Lee KW, Van Cutsem E, Bang YJ, Fuchs CS, Kudaba I, Garrido M, Chung HC, Lee J, Castro HR, Chao J, Wainberg ZA, Cao ZA, Aurora-Garg D, Kobie J, Cristescu R, Bhagia P, Shah S, Tabernero J, Shitara K, Wyrwicz L. Lee KW, et al. Among authors: fuchs cs. Clin Cancer Res. 2022 Aug 15;28(16):3489-3498. doi: 10.1158/1078-0432.CCR-22-0121. Clin Cancer Res. 2022. PMID: 35657979 Clinical Trial.
Rectal cancer.
Benson AB 3rd, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fuchs CS, Grem JL, Hunt S, Leong LA, Lin E, Martin MG, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W Jr, Sofocleous CT, Venook AP, Willett CG, Freedman-Cass DA, Gregory KM. Benson AB 3rd, et al. Among authors: fuchs cs. J Natl Compr Canc Netw. 2012 Dec 1;10(12):1528-64. doi: 10.6004/jnccn.2012.0158. J Natl Compr Canc Netw. 2012. PMID: 23221790
753 results